Enteral Nutrition

Enteral Nutrition

Global Enteral Nutrition Market to Reach US$21.1 Billion by 2030

The global market for Enteral Nutrition estimated at US$13.7 Billion in the year 2023, is expected to reach US$21.1 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Liquid Form, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$16.4 Billion by the end of the analysis period. Growth in the Powder Form segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 9.6% CAGR

The Enteral Nutrition market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Enteral Nutrition Market - Key Trends and Drivers Summarized

Why Is Enteral Nutrition Gaining Attention in Healthcare Circles Today?

Enteral nutrition refers to the method of delivering essential nutrients directly into the gastrointestinal (GI) tract via a feeding tube when a patient is unable to consume food orally but has a functioning digestive system. This form of nutrition is crucial for maintaining the nutritional status and overall health of individuals with conditions that impair swallowing or food intake, such as neurological disorders, stroke, cancer, or trauma. It can be administered through various methods, with nasoenteric tubes used for short-term feeding and ostomy tubes, such as gastrostomy or jejunostomy tubes, preferred for long-term nutritional needs. Enteral nutrition solutions are not one-size-fits-all; they include a broad spectrum of formulas designed to cater to specific patient requirements, such as high-protein, fiber-enriched, and disease-specific formulations for conditions like kidney disease, diabetes, or respiratory disorders. Moreover, enteral feeding is increasingly recognized for its ability to support faster recovery by preserving gut integrity and function, thereby reducing the risk of infections and complications commonly associated with parenteral nutrition (intravenous feeding). The role of enteral nutrition extends beyond just physical sustenance—it also aids in improving the quality of life and enhancing patient comfort by providing a non-invasive alternative for long-term nutritional support.

How Is Technology Shaping Enteral Feeding Devices?

The technological advancements in enteral feeding devices have significantly altered the landscape of nutritional therapy, prioritizing patient safety, precision, and ease of use. Over the past decade, the industry has seen the development of sophisticated enteral feeding pumps equipped with highly sensitive flow rate controls, programmable settings, and alarms to ensure accurate and consistent nutrient delivery. This precision is critical in maintaining optimal nutrient absorption rates and minimizing complications such as refeeding syndrome. Additionally, modern devices now incorporate wireless connectivity features that enable remote monitoring, thereby allowing healthcare providers to track feeding parameters, fluid intake, and patient compliance in real-time, reducing the need for frequent hospital visits. Another breakthrough has been the adoption of ISO-compliant ENFit connectors, which are designed to prevent misconnections—a common but potentially dangerous issue where enteral devices were inadvertently connected to incompatible tubing systems, such as intravenous lines. Moreover, portable and wearable enteral devices have gained popularity, providing patients with greater freedom of movement and a better quality of life, especially for those requiring long-term nutritional support. The integration of sensor technology, digital interfaces, and enhanced materials for tubing and connectors has led to a new era of enteral feeding, where safety and patient comfort are at the forefront of innovation.

Who Benefits Most from Enteral Nutrition?

Enteral nutrition plays an indispensable role in the care and management of various patient groups, particularly those in critical and long-term care settings. Critically ill patients in intensive care units (ICUs), who are often mechanically ventilated or recovering from major surgery, rely heavily on enteral feeding to maintain their nutritional status and support organ function. For oncology patients, enteral nutrition helps counter the effects of aggressive treatments like chemotherapy and radiation, which can severely impact appetite and nutrient absorption, making it a key component in sustaining strength and immune function. Similarly, patients with severe neurological conditions, such as Parkinson’s disease or ALS (amyotrophic lateral sclerosis), benefit significantly from enteral feeding as it bypasses the compromised oral and pharyngeal phases of swallowing. Pediatric patients with congenital anomalies like cerebral palsy or anatomical defects such as cleft palate also depend on enteral nutrition for optimal growth and development. Beyond these high-acuity cases, the elderly population—especially those in long-term care facilities—represents a growing demographic that benefits from enteral nutrition. As this population often faces issues like dysphagia (difficulty swallowing), frailty, or dementia, enteral nutrition helps prevent malnutrition and unintentional weight loss, which are prevalent and potentially life-threatening concerns in geriatric care. The increasing awareness and adoption of enteral feeding in both acute and community settings have broadened its reach, making it a cornerstone in the continuum of care for patients across various stages of health and disease management.

What Is Driving the Enteral Nutrition Market?

The growth in the enteral nutrition market is driven by several factors, including the rising prevalence of chronic diseases, advancements in device technology, a rapidly aging global population, and shifting preferences toward home healthcare. One of the most significant growth drivers is the increasing incidence of chronic and lifestyle diseases such as cancer, diabetes, gastrointestinal disorders, and neurological conditions, which necessitate long-term nutritional support. Technological advancements have also played a pivotal role, with innovations such as portable feeding pumps, user-friendly feeding sets, and improved safety connectors enhancing the overall patient experience and compliance. The development of disease-specific nutritional formulations tailored for conditions like renal failure, hepatic disease, and pulmonary disorders has further expanded the market by catering to diverse patient needs. Additionally, the growing popularity of home-based enteral care, spurred by the increased focus on reducing hospital-acquired infections, has created a surge in demand for at-home enteral nutrition products. This shift has been supported by the availability of sophisticated yet easy-to-use devices that enable safe and effective nutritional management outside traditional healthcare settings. Moreover, regulatory trends and global standardization efforts, such as the implementation of ENFit connectors to enhance patient safety, have contributed to increased adoption rates. Another significant driver is the expanding healthcare infrastructure in emerging economies, where government initiatives and improved access to healthcare services are facilitating the broader use of enteral feeding solutions. These factors, combined with growing awareness of the benefits of personalized nutrition, are set to propel the enteral nutrition market to new heights, making it a critical component in both clinical and home healthcare environments.

Select Competitors (Total 43 Featured) -

• Abbott Laboratories
• Aveanna Healthcare, LLC
• B. Braun Holding GmbH & Co. KG
• Baxter International Inc.
• Danone Nutricia
• Fresenius Kabi AG
• Groupe Danone
• Halyard Health, Inc.
• Johnson & Johnson
• Medtronic Inc.
• Meiji Seika Pharma Co. Ltd.
• Nestle S.A.
• Nutricia
• Perrigo Company Plc
• Reckitt Benckiser Group Plc
• Shield HealthCare, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.